Inventor · disambiguated record
Timothy F. Kowalik
Also filed as: KOWALIK TIMOTHY · KOWALIK TIMOTHY F
13 granted patents·3 pending applications·10 citations·filing 2004–2022
87Inventor score
Top patents by PatentIndex Score
16 records- 0182US8361976B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2005·Granted Jan 29, 2013·3 cites·28 claims
- 0281US12084660B2Therapeutic alteration of transplantable tissues through In Situ or Ex Vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2022·Granted Sep 10, 2024·0 cites·11 claims
- 0378US8933045B2Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)KOWALIK TIMOTHY F·Filed 2011·Granted Jan 13, 2015·4 cites·17 claims
- 0476US8940709B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2013·Granted Jan 27, 2015·1 cites·6 claims
- 0572US11484570B2Targeting cell tropism receptors to inhibit cytomegalovirus infectionUNIV MASSACHUSETTS·Filed 2018·Granted Nov 1, 2022·1 cites·2 claims
- 0672US11220686B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2019·Granted Jan 11, 2022·0 cites·14 claims
- 0772US9562232B2Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)UNIV MASSACHUSETTS·Filed 2014·Granted Feb 7, 2017·1 cites·25 claims
- 0871US12268901B2Targeting cell tropism receptors to inhibit cytomegalovirus infectionUNIV MASSACHUSETTS·Filed 2022·Granted Apr 8, 2025·0 cites·5 claims
- 0962US10260066B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2015·Granted Apr 16, 2019·0 cites·9 claims
- 1060US9150861B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2015·Granted Oct 6, 2015·0 cites·6 claims
- 1153US10227591B2Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)UNIV MASSACHUSETTS·Filed 2016·Granted Mar 12, 2019·0 cites·26 claims
- 1250US2004248839A1RNAi targeting of virusesUNIV MASSACHUSETTS·Filed 2004·Application pending·0 cites
- 1349US7776569B2Virally-encoded RNAs as substrates, inhibitors and delivery vehicles for RNAiUNIV MASSACHUSETTS·Filed 2004·Granted Aug 17, 2010·0 cites·31 claims
- 1449US2005186589A1Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAiUNIV MASSACHUSETTS·Filed 2004·Application pending·0 cites
- 1547US12091664B2Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservationUNIV MASSACHUSETTS·Filed 2019·Granted Sep 17, 2024·0 cites·11 claims
- 1634US2011151430A1VIRUS-SPECIFIC miRNA SIGNATURES FOR DIAGNOSIS AND THERAPEUTIC TREATMENT OF VIRAL INFECTIONUNIV MASSACHUSETTS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy F. Kowalik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →